BIO vs KBH · rev $651.0M vs P/E 10, rev $2.19B
BIO (BIO) versus KB Home (KBH) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
KB Home (KBH) is a residential construction company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported KBH revenue for 2026-05-31 was $2.19B. Net income was $60.8M. KBH currently screens at market cap $3.28B and trailing P/E 10.1.
BIO currently screens at market cap $0. KBH currently screens at market cap $3.28B and trailing P/E 10.1.
Not investment advice. Open the BIO and KBH stock pages for the full models.
Not investment advice.